Current and Future Treatment Approaches in Transthyretin Familial Amyloid Polyneuropathy.
about
The Race of 10 Synthetic RNAi-Based Drugs to the Pharmaceutical Market.Negative effects of transthyretin in high myopic vitreous on diabetic retinopathy.Genetic and clinical characteristics of hereditary transthyretin amyloidosis in endemic and non-endemic areas: experience from a single-referral center in Japan.Transthyretin familial amyloid polyneuropathy: an update.Amyloid deposition in a mouse model humanized at the transthyretin and retinol-binding protein 4 loci.RNA Therapeutics in Oncology: Advances, Challenges, and Future Directions.Methionine oxidized apolipoprotein A-I at the crossroads of HDL biogenesis and amyloid formation.Immunoglobulin light chain amyloidosis diagnosis and treatment algorithm 2018.Understanding the Disease Course and Therapeutic Benefit of Tafamidis Across Real-World Studies of Hereditary Transthyretin Amyloidosis with Polyneuropathy: A Proof of Concept for Integrative Data Analytic Approaches.
P2860
Q39227810-B0760761-0E9C-4813-923A-A80F2FB35657Q47104291-F919A9DA-83D5-4309-8CD8-F527BF0A7777Q47206219-20227C4D-A127-41E4-AF3A-AB9770AB13ADQ47562649-CDA59890-0E3F-49D9-B99B-48B8011CBF3CQ47657797-DFDADC97-662A-4468-8462-88860053F8FAQ47786398-C919FA77-B27A-4EB6-8DF1-9B7726B76197Q52688145-91F46ED1-A1C5-4D58-B874-1B29C0F0806EQ55023498-6851B1CD-3F8D-4EBD-8260-12A54D22AF1AQ55215108-71D75D0D-820C-454C-B472-898F20D265D4
P2860
Current and Future Treatment Approaches in Transthyretin Familial Amyloid Polyneuropathy.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Current and Future Treatment Approaches in Transthyretin Familial Amyloid Polyneuropathy.
@en
type
label
Current and Future Treatment Approaches in Transthyretin Familial Amyloid Polyneuropathy.
@en
prefLabel
Current and Future Treatment Approaches in Transthyretin Familial Amyloid Polyneuropathy.
@en
P2860
P1476
Current and Future Treatment Approaches in Transthyretin Familial Amyloid Polyneuropathy.
@en
P2093
Philippe Kerschen
P2860
P2888
P356
10.1007/S11940-016-0436-Z
P577
2016-12-01T00:00:00Z